All News

Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.

Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.

Data from 52 studies show that antimicrobial stewardship programs largely reduced antibiotic use for pediatric care.

The drive for personalized approaches to cancer have helped to create treatments for patients with rare cancers who have few, if any, options.

Those seeking abortion were found to have triple the risk of a psychiatric disorder compared to the general population.

Their exclusion ripples into demand estimates for pharmacists, leading to a distorted picture of pharmacist demand and, ultimately, impacting the number of individuals choosing to enter the profession.

US adults have a slightly stronger preference for fewer adverse events in relation to pediatric COVID-19 vaccination, study results show.

Idecabtagene vicleucel prolonged progression-free survival by more than 1 year in a difficult-to-treat patient population with relapsed or refractory multiple myeloma.

Association of Black Health-System Pharmacists focuses on advocacy, collaboration, education, leadership, and research.

Analysis shows average monthly premiums for stand-alone plans will rise 10% to $43.

Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.

Study findings confirmed that in asthma, chronic obstructive pulmonary disease, HIV, and influenza, census data differed from the epidemiological data.

The new findings, which include updated data, contradict results of a previous analysis by the same investigators.

Although investigative team is predominantly investigating Priscilicidin for topical applications, they are not ruling out potential oral applications.

HER2-low disease demands a different approach from that of HER2-negative disease.

Amanda Ryan, the director of Education for the Pharmacy Quality Alliance (PQA), discusses a new PQA program to teach pharmacy and other health professions students the basics of quality measurement and strategies to improve medication safety, adherence and appropriate use.

The patient's list of medications reveals significant drug interactions to be addressed.

Study shows no robust differences in blood pressure, heart rate, lipids, and glucose measurements in children conceived using assisted reproductive technologies.

Results of 2 phase 3 clinical trials demonstrate better response rate beyond the primary endpoint analysis at week 16 to more than 55 at week 55.

Investigators focus on whether legalization of the drug is associated with an increase in health care use for the psychotic disorder.

Streptolysin O appears to influence the pathogenesis of Streptococcus group A and direct mutation-mediated virulence in a host.

Low cognitive functioning and cognitive decline have been linked to an increased risk of morbidity and mortality.

The association with subgroups of gene variations based on expression or function should be assessed in larger studies, investigators say.

Expanded indication for abrocitinib (Cibinqo; Pfizer Inc) includes patients 12 to <18 years of age with refractory, moderate-to-severe atopic dermatitis that is not adequately controlled with other systemic medications.

Learn strategies to safeguard use of the intravenous administration products to protect patients.

Despite the large number of prescription products available, nondrug therapies often work just as well.

Trial meets its primary endpoint of progression-free survival regardless of mismatch repair status in patients with stage 3 or 4 or recurrent endometrial carcinoma.

By binding to and inhibiting RANKL, denosumab decreases the production and activity of osteoclasts, resulting in reduced bone loss.

New guidance provides recommendations on infection prevention strategies, performance measures, and how to implement these approaches.

Earlier this week, the FDA Oncologic Drugs Advisory Committee also voted 8 to 5 in support of data for dostarlimab-gxly in rectal cancer.